News

CPhA CEO Perry Eisenschmid appeared before the House of Commons Finance Committee pre-budget consultations to present CPhA recommendations for the 2016 federal budget.

As the national voice of the profession, CPhA is committed to working with the government to ensure that  pharmacists’ perspectives and concerns are addressed in the development and implementation of assisted dying legislation.

CPhA welcomes the move by provincial and territorial health ministers to form a working group to improve access to prescription drugs — an important step in the collaborative efforts between Canadian governments to ensure all Canadians have access to the medications and pharmacy services they need.

As Ministers of Health from across the country prepare to gather for their pan-Canadian meeting, the Canadian Pharmacists Association has released the preliminary results of a study – one that delves deeper into the costs and other considerations associated with various pharmacare models, including universal pharmacare. 

Pharmacists who screened at-risk patients for chronic kidney disease found previously unrecognized disease in 1 of every 6.4 patients tested, according to a study published in the Canadian Pharmacists Journal.

CPhA welcomes Health Canada's proposal to change the federal prescription status of naloxone, a medication that has the potential to significantly reduce the frequency of deaths that occur with opioid overdosage.

Today’s announcement is an important step towards fully restoring the health coverage refugees receive under the Interim Federal Health Program.

CPhA is pleased to see important and relevant issues to the pharmacy profession take prominence throughout the ministerial mandate letters and looks forward to working with the Health Minister to achieve her mandate.